Dr. Kaleb Yohay, MD
Claim this profileNew York University Langone Medical Center
Studies Neurofibromatosis
Studies Lymphoma
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
More about Kaleb Yohay, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Kaleb Yohay, MD has experience with
- Selumetinib
- Brigatinib
- Neratinib
Breakdown of trials Kaleb Yohay, MD has run
Lymphoma
Malignant peripheral nerve sheath tumor
Schwannoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kaleb Yohay, MD specialize in?
Kaleb Yohay, MD focuses on Neurofibromatosis and Lymphoma. In particular, much of their work with Neurofibromatosis has involved NF2 positive patients, or patients who are undergoing treatment.
Is Kaleb Yohay, MD currently recruiting for clinical trials?
No, Kaleb Yohay, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Kaleb Yohay, MD has studied deeply?
Yes, Kaleb Yohay, MD has studied treatments such as Selumetinib, Brigatinib, Neratinib.
What is the best way to schedule an appointment with Kaleb Yohay, MD?
Apply for one of the trials that Kaleb Yohay, MD is conducting.
What is the office address of Kaleb Yohay, MD?
The office of Kaleb Yohay, MD is located at: New York University Langone Medical Center, New York, New York 10016 United States. This is the address for their practice at the New York University Langone Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.